ALBHIGH SIGNALOPERATIONAL10-K

Albemarle is executing a major strategic pivot by divesting its Ketjen Refining Solutions business and Eurecat joint venture while dramatically reducing capital expenditures by 65%.

This represents a fundamental transformation of Albemarle's business portfolio, with the company shedding major operating segments to focus on core operations. The divestiture activity, combined with massive reductions in capex and R&D spending, suggests either a strategic refocus or potential capital constraints requiring asset sales to improve financial flexibility.

Comparing 2026-02-11 vs 2025-02-12View on EDGAR →
FINANCIAL ANALYSIS

Albemarle's financials show a company in dramatic transition, with gross profit surging 969% while operating losses improved significantly from -$1.8B to -$367M. The company sharply reduced capital intensity with capex falling 65% and R&D declining 41%, while operating cash flow nearly doubled to $1.3B. Working capital declined substantially with inventory and receivables both down ~20%, suggesting either improved efficiency or reduced business scale, while the company maintained stable cash reserves during this major restructuring period.

FINANCIAL STATEMENT CHANGES
Gross Profit
P&L
+969.3%
$62.5M→$668.7M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Operating Cash Flow
Cash Flow
+82.6%
$702.1M→$1.3B

Operating cash flow surged 82.6% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+79.3%
-$1.8B→-$367.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Capital Expenditure
Cash Flow
-65%
$1.7B→$589.8M

Capex reduced 65% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Net Income
P&L
+56.7%
-$1.2B→-$510.6M

Net income grew 56.7% — bottom-line growth signals improving overall business health.

R&D Expense
P&L
-40.7%
$86.7M→$51.4M

R&D spending cut 40.7% — could signal cost discipline or concerning reduction in innovation investment.

Inventory
Balance Sheet
-21.5%
$1.5B→$1.2B

Inventory reduced 21.5% — lean inventory management or demand outpacing supply.

Accounts Receivable
Balance Sheet
-20%
$742.2M→$593.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

SG&A Expense
P&L
-11%
$618.0M→$550.0M

SG&A reduced 11% — improved cost efficiency or headcount reduction improving operating margins.

Cash & Equivalents
Balance Sheet
+10.4%
$555.3M→$613.1M

Cash grew 10.4% — improving liquidity position supports investment and shareholder returns.

LANGUAGE CHANGES
NEW — 2026-02-11
PRIOR — 2025-02-12
ADDED
Form 10-K Summary 153 Signatures 154 Albemarle Corporation and Subsidiaries PART I Item 1.
On October 25, 2025, the Company signed a definitive agreement to divest the controlling ownership interest of Ketjen s Refining Solutions business to ChemCat AcquisitionCo, LLC and contribute the remaining ownership interest to ChemCat Holdings, LP, a newly formed limited partnership ( Holdco ).
The Refining Solutions business being divested and contributed is defined as the Company s Ketjen reportable segment, excluding its PCS business and the Company s 50% ownership interest in Eurecat S.A.
In a separate transaction, on January 23, 2026, the Company completed the sale of its 50% ownership interest in Eurecat S.A., a joint venture included in the Ketjen segment, to Axens SA.
Following the completion of these transactions, the Company will retain the PCS business and common units of Holdco initially representing a 49% interest.
+7 more — sign up free →
REMOVED
Form 10-K Summary 151 Signatures 152 Albemarle Corporation and Subsidiaries PART I Item 1.
Effective November 1, 2024, we transitioned our operating structure from two core global business units - Energy Storage and Specialties - to a fully integrated functional model designed to increase agility, deliver significant cost savings and maintain long-term competitiveness.
In addition, our Ketjen business continues to be operated under a separate, wholly-owned subsidiary.
We will continue to report results across three existing operating segments: Energy Storage, Specialties and Ketjen.
Lithium is a key component in products and processes used in a variety of applications and industries, which include lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, various life science applications, as well as intermediates in the pharmaceutical industry, among other applications.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →